Charles River debuts AI diagnostic tool to cut down pathology timelines

Charles River is rolling out an artificial intelligence-backed digital pathology platform with a goal of trimming at least one week from standard pathology timelines and workflows. Charles River is rolling out an artificial intelligence-backed digital pathology platform with a goal of trimming at least one week from standard pathology timelines and workflows. Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Trending Biologics Clinical Development Ophthalmology Cell & Gene Therapy Drug Development Small Molecule Research & Development Fierce 50 Special Report Awards Gala Awards Outsourcing Awards Innovation…

Source: FierceBiotech